Farhad Ravandi

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0002-7621-377X

发表论文 2658 篇 · 总被引 72067 次 · h-index 130

代表论文

• Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia (2026 · Haematologica · 被引 1)
• Outcomes of adult patients with Li‐Fraumeni syndrome and myeloid neoplasms (2026 · Cancer)
• Data from Investigational Clinical Trial Agents versus Conventional Second Salvage Therapies in Patients with Relapsed/Refractory Acute Myeloid Leukemia (2026)
• Supplementary Data 1 from Investigational Clinical Trial Agents versus Conventional Second Salvage Therapies in Patients with Relapsed/Refractory Acute Myeloid Leukemia (2026)
• Combination therapy with Nelarabine, Pegaspargase and Venetoclax for Adults Patients with R/R T-cell ALL/LBL (2026 · Blood Neoplasia)
• Acute Myeloid Leukemia With KMT2A Amplification: A TP53-Alteration-Enriched Subgroup Associated With Chromoanagenesis and Poor Prognosis (2026 · Modern Pathology)